AJKD Blog

Atrial fibrillation is common among patients with kidney failure treated with hemodialysis. A recent study published in AJKD by Winkelmayer et al examined the efficacy and safety of apixaban for atrial fibrillation in patients on dialysis. AJKDBlog’s Interviews Editor Timothy Yau chatted with author Wolfgang C. Winkelmayer about the clinical conundrum of both increased stroke and increased bleeding risk in patients on dialysis and how this affects the decision to anticoagulate. They review [...]

NephMadness 2026 is still fresh in our memories, but it’s already time to start thinking about NephMadness 2027! Which topics would you like to see in next year’s edition of the madness? Last year you demanded more Animal House (and we were happy to oblige): And this suggestion from 2024 came to fruition: Want to see your name in next year’s post? Then leave a comment with your ideas for NephMadness 2027, or post them on the social media platform of your choice with the [...]

Dr. Linda-Marie Lavenburg is an Assistant Professor of Medicine at the University of Pittsburgh Renal-Electrolyte Division. She is an internal-medicine and pediatric-trained physician, and a dual board-certified practicing adult nephrology and obesity medicine physician. Her research uses real-world clinical data to identify gaps in guideline-recommended kidney disease management. She also strives to raise awareness of kidney disease through community outreach and partnerships and to empower [...]

Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired their study, the basic approach taken, what was learned, and why it matters. We hope our readers will find this valuable in helping them keep up with the latest research in the field of nephrology. Highlights from the June 2026 issue: Dialysis Facility Closures in the US From 2018 to 2024: A Serial Cross-Sectional Study by Meri R.J. Varkila et al. [...]

IgA nephropathy (IgAN) is the most common immune-mediated glomerular disease worldwide. Advanced understanding of the role of complement in IgAN pathogenesis has motivated the development of complement inhibition as a therapeutic strategy. In a Mini-Review recently published in AJKD, authors Jia Wei Teh, Sinead Stoneman, and Michelle M. O’Shaughnessy provide an overview of the role of complement in the pathogenesis and progression of IgAN and summarize current and emerging [...]